WEB : www . tevapharm . com

The parent company of Actavis is one of the leading manufacturers in generic drugs in the world , although it has proprietary pharmaceuticals under its massive umbrella of services as well . $ 21.9bn in revenue helps to employ over 43,000 people around the world , and an operating income of just under $ 4bn ensures the longevity of the company . The latest acquisitions of Teva include Ratiopharm , a $ 5bn deal that significantly increased the reach of Teva into remote parts of Europe . In terms of proprietary pharmaceuticals , Teva recently purchased Cephalon for just under $ 7bn .

32 November 2017